Myogenic differentiation and histologic grading are major prognostic determinants in retroperitoneal liposarcoma

American Journal of Surgical Pathology

Volumn 39, Issue 3, 2015, Pages 383-393

  Gronchi, Alessandro ^a   Collini, Paola ^a   Miceli, Rosalba ^a   Valeri, Barbara ^a   Renne, Salvatore L ^a   Dagrada, Gianpaolo ^a   Fiore, Marco ^a   Sanfilippo, Roberta ^a   Barisella, Marta ^a   Colombo, Chiara ^a   Morosi, Carlo ^a   Stacchiotti, Silvia ^a   Casali, Paolo G ^a   Dei Tos, Angelo P ^b   Pilotti, Silvana ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Azienda ULSS 9   (Italy)

Author keywords

dedifferentiation; liposarcoma; myogenic differentiation; prognosis; retroperitoneal sarcoma; rhabdomyoblastic differentiation; sarcoma; survival

Indexed keywords

TUMOR MARKER;

ADULT; AGED; CANCER GRADING; CELL DIFFERENTIATION; CHEMISTRY; DISEASE FREE SURVIVAL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; ITALY; KAPLAN MEIER METHOD; LIPOSARCOMA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUSCLE DEVELOPMENT; PATHOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SECONDARY; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; CELL DIFFERENTIATION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; ITALY; KAPLAN-MEIER ESTIMATE; LIPOSARCOMA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUSCLE DEVELOPMENT; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84924074066     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000366     Document Type: Article

References (36)

1. Fletcher CDM, Bridge JA, Hogendoom PCW, et al. WHO Classification of tumours of Soft Tissue and Bone. Lyon: IARC; 2013.
2. Dalal KM, Kattan MW, Antonescu CR, et al. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg. 2006;244:381-391.
3. Dei Tos AP, Doglioni C, Piccinin S, et al. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. J Pathol. 2000;190:531-536.
4. Pilotti S, Della Torre G, Lavarino C, et al. Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22. J Pathol. 1998;185:188-190.
5. Italiano A, Bianchini L, Keslair F, et al. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon. Int J Cancer. 2008;122:2233-2241.
6. Crago AM, Socci ND, DeCarolis P, et al. Copy number losses define subgroups of dedifferentiated liposarcoma with poor prognosis and genomic instability. Clin Cancer Res. 2012;18:1334-1340.
7. Binh MB, Guillou L, Hostein I, et al. Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk. A study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas. Am J Surg Pathol. 2007;31:1557-1566.
8. Mussi C, Collini P, Miceli R, et al. Prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of patients surgically treated at a single institution. Cancer. 2008;113: 1657-1665.
9. Bonvalot S, Raut CP, Pollock RE, et al. Technical considerations in surgery for retroperitoneal sarcomas: position paper from e-surge, a master class in sarcoma surgery, and EORTC-STBSG. Ann Surg Oncol. 2012;19:2981-2991.
10. Stacchiotti S, Collini P, Messina A, et al. High-grade soft-tissue sarcomas: tumor response assessment-pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria. Radiology. 2009;251:447-456.
11. Evans HL. Atypical lipomatous tumor, its variants, and its combined forms: a study of 61 cases, with a minimum follow-up of 10 years. Am J Surg Pathol. 2007;31:1-14.
12. Trojani M, Contesso G, Coindre JM, et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer. 1984;33:37-42.
13. Institute for Statistics and Mathematics of WU (Wirtschaftsuniversita t Wien): The R Project for Statistical Computing. Available at: http://www.r-project.org/. Accessed June 26, 2014.
14. Marubini E, Valsecchi MG. Analysing Survival Data for Clinical Trials and Observational Studies. Chichester: Wiley; 1995.
15. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141-1154.
16. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989;8:551-561.
17. Moons KGM, Donders ART, Steyerberg EW, et al. Penalized maximum likelihood estimation to directly adjust diagnostic and prognostic prediction models for overoptimism: a clinical example. J Clin Epidemiol. 2004;57:1262-1270.
18. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239-241.
19. Sioletic S, Dal Cin P, Fletcher CD, et al. Well-differentiated and dedifferentiated liposarcomas with prominent myxoid stroma: analysis of 56 cases. Histopathology. 2013;62:287-293.
20. Kdria Sayed P, Ramjiand F, Parharm DM. Rhabdomyomas and rhabdomyosarcomas. In: Miettinen M, ed. Modern Soft Tissue Pathology. NY: Cambridge University Press; 2010:546-573.
21. Lewis JJ, Leung D, Woodruff JM. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228:355-365.
22. Coindre JM, Terrier P, Guillou L, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer. 2001;91: 1914-1926.
23. Gronchi A, Miceli R, Shurell E, et al. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histologyspecific overall survival and disease-free survival nomograms built on major sarcoma center datasets. J Clin Oncol. 2013;31:1649-1655.
24. Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27:31-37.
25. Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2009; 27:24-30.
26. Bonvalot S, Miceli R, Berselli M, et al. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control. Ann Surg Oncol. 2010;17:1507-1514.
27. Gronchi A, Miceli R, Colombo C, et al. Frontline extended surgery is associated with improved survival in retroperitoneal lowintermediate grade soft tissue sarcomas. Ann Oncol. 2012;23: 1067-1073.
28. Fabre-Guillevin E, Coindre JM, de Saint Aubain Somerhausen N, et al. Retroperitoneal liposarcomas: follow-up analysis of dediffer-entiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas. Cancer. 2006;106:2725-2733.
29. Tseng W, Madewell J, Wei W, et al. Locoregional disease patterns in well differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection? Ann Surg Oncol. 2014;21: 2136-2143.
30. Keung EZ, Hornick JL, Bertagnolli MM, et al. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery. J Am Coll Surg. 2014;218:206-217.
31. Fletcher CD, Gustafson P, Rydholm A, et al. Clinicopathologic reevaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol. 2001;19:3045-3050.
32. Stock N, Chibon F, Binh MB, et al. Adult-type rhabdomyosarcoma: analysis of 57 cases with clinicopathologic description, identification of 3 morphologic patterns and prognosis. Am J Surg Pathol. 2009;33:1850-1859.
33. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13:4279-4295.
34. Rodriguez AM, Elabd C, Delteil F, et al. Adipocyte differentiation of multipotent cells established from human adipose tissue. Biochem Biophys Res Commun. 2004;315:255-263.
35. Hatley ME, Tang W, Garcia MR, et al. A mouse model of rhabdomyosarcoma originating from the adipocyte lineage. Cancer Cell. 2012;22:536-546.
36. Paulson V, Chandler G, Rakheja D, et al. High-resolution array CGH identifies common mechanisms that drive embryonal rhabdomyosarcoma pathogenesis. Genes Chromosomes Cancer. 2011; 50:397-408.